What the food supply chain can learn from the pharma industry.

Advanced therapy clinical trials are growing, with a record number of therapies being approved in 2021. This increase in approvals has led many to predict that the commercialization of advanced therapies is not far away .

With the continued pressure to reduce costs through innovations and efficiencies all while delivering faster sample results, the use of an On-line Water Bioburden Analyzer (OWBA) is one way companies can meet these demands. OWBA technology has the flexibility to be used for purified water, water for injections or even cleaning verifications and provides real time microbial detection as an early warning for system health. The benefits for using an OWBA include the potential for energy savings through reduced loop sanitation, labor cost reduction and improved product quality and process understanding.

Most informed consent forms are not patient focused and do not support the needs of the study participant! Use of electronic consent can help improve the current paper document approach, but there is more to it than just replacing paper with a multi-media eConsent. What does it take to make eConsent patient centric?

The composition of pharmaceutical tablets and the distribution of ingredients therein can be determined using chemical imaging by vibrational microscopy.